Medline has issued an urgent medical device recall for 4,300 blood culture kits. The Class II recall went into effect December 24, but FDA issued a recall notice February 9. The recall impacts kits ...

NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, ...

“Medline’s IPO was the largest private equity-backed IPO of all time, the largest healthcare IPO ever and the largest public offering of 2025, having traded up strongly on debut,” Robert Schmidt, ...

Jan 12 (Reuters) - Brokerages began coverage of Medline (MDLN.O), opens new tab with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's ...

Investing.com -- Wall Street analysts initiated coverage on Medline Industries, pointing to high visibility on revenue growth, a differentiated private-label model and scope for margin expansion after ...

Similarly, JPMorgan has given Medline an Overweight rating, also with a $50 price target, highlighting the company’s substantial market share and leading position in the med-surg distribution business ...

Medline has struck a series of new and expanded partnerships with health systems in recent months, reinforcing its position as a major supply chain player in both medical-surgical and laboratory ...

The First Trust U.S. Equity Opportunities ETF (NYSE: FPX) is solidifying its status as a leader for newly public companies after becoming the first ETF to add Medline Industries (NASDAQ: MDLN) ...

The banner across Medline's homepage today reads, "We're public." It's a bit of an understatement. The Northfield-based global medical supplies company on Dec. 16 offered about 216 million shares at ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

Medline Inc. completed a record-setting $6.26B IPO, allocating proceeds primarily to reduce leveraged buyout debt from 2021. MDLN operates globally with $20.6B YTD revenue, stable 10% growth, and ...

When the Mills family sold Medline Inc. to private equity in one of the largest leveraged buyouts ever, the $32 billion deal seemed the apotheosis of a Covid economy defined by low interest rates and ...